Cargando…
Cardio-toxicity among patients with sarcoma: a cardio-oncology registry
BACKGROUND: Chemotherapy induced cardio-toxicity has been recognized as a serious side effect since the first introduction to anthracyclines (ANT). Cardio-toxicity among patients with breast cancer is well studied but the impact on patients with sarcoma is limited, even though they are exposed to hi...
Autores principales: | Shamai, Sivan, Rozenbaum, Zach, Merimsky, Ofer, Derakhshesh, Matthew, Moshkovits, Yonatan, Arnold, Joshua, Topilsky, Yan, Arbel, Yaron, Laufer-Perl, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325299/ https://www.ncbi.nlm.nih.gov/pubmed/32605637 http://dx.doi.org/10.1186/s12885-020-07104-9 |
Ejemplares similares
-
Immune Checkpoint Inhibitor-Induced Myocarditis vs. COVID-19 Vaccine-Induced Myocarditis—Same or Different?
por: Zornitzki, Lior, et al.
Publicado: (2022) -
Valvular Heart Disease following Anthracycline Therapy—Is It Time to Look beyond Ejection Fraction?
por: Zahler, David, et al.
Publicado: (2022) -
Cardio-Oncology: mechanisms of cardiovascular toxicity
por: Markman, Timothy M., et al.
Publicado: (2018) -
Cardio-oncology: management of cardiovascular toxicity
por: Markman, Timothy M., et al.
Publicado: (2019) -
ONCOR: design of the Dutch cardio-oncology registry
por: Kamphuis, J. A. M., et al.
Publicado: (2020)